MEDTIDE Appoints New CFO and Revamps Key Management Positions

Stock News07-31

MEDTIDE (03880) has announced a series of key management changes, effective from July 31, 2026. Ms. Ding Lijun has been appointed as the Chief Financial Officer, where she will oversee the group's overall financial strategy and management.

Effective July 31, 2026, Mr. Wu Dongcheng has resigned from his roles as (i) joint company secretary, (ii) authorized representative under Rule 3.05 of the Hong Kong Stock Exchange Listing Rules, and (iii) representative for service of process and notices in Hong Kong under the Listing Rules and the Companies Ordinance. Concurrently, Ms. Li Lingmei has stepped down as (i) board secretary, (ii) joint company secretary, and (iii) authorized representative. Ms. Li will continue to serve as an executive director of the company.

Following Ms. Li's resignation as board secretary, Ms. Ding Lijun has been appointed as the new board secretary effective July 31, 2026. Additionally, after Ms. Li's resignation as authorized representative, Dr. Xu Qi, the company's chairman, executive director, and CEO, has been appointed as the authorized representative from the same date. Following the resignations of Mr. Wu and Ms. Li as joint company secretaries, Mr. Chen Zhen has been appointed as company secretary, authorized representative, and legal process agent, effective July 31, 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1112713365?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 16:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112713365","market":"nz","top_or_hot":-1,"title":"MEDTIDE Appoints New CFO and Revamps Key Management Positions","media":"Stock News","content":"<p><b>MEDTIDE (03880)</b> has announced a series of key management changes, effective from July 31, 2026. Ms. Ding Lijun has been appointed as the Chief Financial Officer, where she will oversee the group's overall financial strategy and management.<br><br>Effective July 31, 2026, Mr. Wu Dongcheng has resigned from his roles as (i) joint company secretary, (ii) authorized representative under Rule 3.05 of the Hong Kong Stock Exchange Listing Rules, and (iii) representative for service of process and notices in Hong Kong under the Listing Rules and the Companies Ordinance. Concurrently, Ms. Li Lingmei has stepped down as (i) board secretary, (ii) joint company secretary, and (iii) authorized representative. Ms. Li will continue to serve as an executive director of the company.<br><br>Following Ms. Li's resignation as board secretary, Ms. Ding Lijun has been appointed as the new board secretary effective July 31, 2026. Additionally, after Ms. Li's resignation as authorized representative, Dr. Xu Qi, the company's chairman, executive director, and CEO, has been appointed as the authorized representative from the same date. Following the resignations of Mr. Wu and Ms. Li as joint company secretaries, Mr. Chen Zhen has been appointed as company secretary, authorized representative, and legal process agent, effective July 31, 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEDTIDE Appoints New CFO and Revamps Key Management Positions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEDTIDE Appoints New CFO and Revamps Key Management Positions\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-31 16:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>MEDTIDE (03880)</b> has announced a series of key management changes, effective from July 31, 2026. Ms. Ding Lijun has been appointed as the Chief Financial Officer, where she will oversee the group's overall financial strategy and management.<br><br>Effective July 31, 2026, Mr. Wu Dongcheng has resigned from his roles as (i) joint company secretary, (ii) authorized representative under Rule 3.05 of the Hong Kong Stock Exchange Listing Rules, and (iii) representative for service of process and notices in Hong Kong under the Listing Rules and the Companies Ordinance. Concurrently, Ms. Li Lingmei has stepped down as (i) board secretary, (ii) joint company secretary, and (iii) authorized representative. Ms. Li will continue to serve as an executive director of the company.<br><br>Following Ms. Li's resignation as board secretary, Ms. Ding Lijun has been appointed as the new board secretary effective July 31, 2026. Additionally, after Ms. Li's resignation as authorized representative, Dr. Xu Qi, the company's chairman, executive director, and CEO, has been appointed as the authorized representative from the same date. Following the resignations of Mr. Wu and Ms. Li as joint company secretaries, Mr. Chen Zhen has been appointed as company secretary, authorized representative, and legal process agent, effective July 31, 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03880","symbol_name":"泰德医药","start_time":0,"source_url":"","article_id":"1112713365","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112713365","pubTimestamp":1785487097,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"MEDTIDE (03880) has announced a series of key management changes, effective from July 31, 2026. Ms. Ding Lijun has been appointed as the Chief Financial Officer, where she will oversee the group's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03880":"泰德医药","BK1141":"生命科学工具和服务"},"translate_title":"MEDTIDE 任命新首席财务官并调整关键管理职位","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03880":1},"content_text":"MEDTIDE (03880) has announced a series of key management changes, effective from July 31, 2026. Ms. Ding Lijun has been appointed as the Chief Financial Officer, where she will oversee the group's overall financial strategy and management.Effective July 31, 2026, Mr. Wu Dongcheng has resigned from his roles as (i) joint company secretary, (ii) authorized representative under Rule 3.05 of the Hong Kong Stock Exchange Listing Rules, and (iii) representative for service of process and notices in Hong Kong under the Listing Rules and the Companies Ordinance. Concurrently, Ms. Li Lingmei has stepped down as (i) board secretary, (ii) joint company secretary, and (iii) authorized representative. Ms. Li will continue to serve as an executive director of the company.Following Ms. Li's resignation as board secretary, Ms. Ding Lijun has been appointed as the new board secretary effective July 31, 2026. Additionally, after Ms. Li's resignation as authorized representative, Dr. Xu Qi, the company's chairman, executive director, and CEO, has been appointed as the authorized representative from the same date. Following the resignations of Mr. Wu and Ms. Li as joint company secretaries, Mr. Chen Zhen has been appointed as company secretary, authorized representative, and legal process agent, effective July 31, 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1112713365","isCrawlerRequest":true}